SurModics, Inc. – Value Analysis (NASDAQ:SRDX) : November 14, 2017 Tue, 14 Nov 2017 20:39:20 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives SurModics, Inc. a score of 67. Our analysis is based on comparing SurModics, Inc. with the following peers – Nektar Therapeutics, Thermo Fisher Scientific Inc., Heron Therapeutics Inc, Abbott Laboratories, pSivida Corp., Johnson & Johnson, PerkinElmer, Inc., Enzo Biochem, Inc., Alkermes Plc and Agilent Technologies, Inc. (NKTR-US, ... Read more
(Read more...)
Surmodics Inc (SRDX): What Can We Expect In The Future? Tue, 14 Nov 2017 00:48:50 +0000 Based on the latest analyst prediction, Surmodics Inc (NASDAQ:SRDX) is estimated to immensely contract its earnings by beyond -150% next year. Presently, with an EPS of $0.298, we can expectRead More...
SurModics, Inc. breached its 50 day moving average in a Bullish Manner : SRDX-US : November 13, 2017 Mon, 13 Nov 2017 12:23:17 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for SurModics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
SurModics posts 4Q profit Wed, 08 Nov 2017 13:03:34 +0000 The Eden Prairie, Minnesota-based company said it had profit of 3 cents per share. Earnings, adjusted for non-recurring costs and amortization costs, were 18 cents per share. The drug delivery technology ...
Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance Wed, 08 Nov 2017 12:30:00 +0000 Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 fourth quarter, ended September 30, 2017 and financial outlook for fiscal 2018.
SurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : November 2, 2017 Thu, 02 Nov 2017 12:30:41 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for SurModics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum Thu, 26 Oct 2017 20:05:00 +0000 Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and information systems and chief financial officer, will make a presentation to the investment community at the Canaccord Genuity Medical Technologies and Diagnostics ...
ETFs with exposure to SurModics, Inc. : October 23, 2017 Mon, 23 Oct 2017 15:06:00 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SurModics, Inc. Here are 5 ETFs with the largest exposure to SRDX-US. Comparing the performance and risk of SurModics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 1.97 (median winner: 1.53)
Above 40wkMA: 23% (median winner: 35%)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.